KRAS and familial pancreatic carcinoma: A role for Smad signaling in suppressing oncogenic K-Ras induced tumorigenicity is supported by a study demonstrating that inactivation of Smad4 accelerated K-Ras (inducing G12D mutation) induced pancreatic cancer development and progression [50].